Biotech entity
All 1 tracked stories fall under one category: pharma. Monica Guerra is most often covered alongside China, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Monica Guerra, all published on March 9, 2026.
Last mentioned: Mar 9, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Monica Guerra is most often covered alongside China, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Monica Guerra, all published on March 9, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Monica Guerra. Shared-story counts are live from our verified record — not editorial picks.
A new Morgan Stanley report identifies 'affordability politics' as a primary risk for the pharmaceutical sector ahead of the 2026 midterm elections. The firm warns that targeted legislative measures to lower prescription drug costs could create significant pricing pressure on high-margin brand-name drugs.
Monica Guerra is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
